Intellectus Partners LLC Trims Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Intellectus Partners LLC trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 7.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,705 shares of the financial services provider’s stock after selling 1,051 shares during the period. Intellectus Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,995,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of IBB. Main Management ETF Advisors LLC raised its stake in iShares Biotechnology ETF by 2.6% in the 2nd quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock valued at $79,451,000 after purchasing an additional 14,535 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its position in shares of iShares Biotechnology ETF by 24.6% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock valued at $29,792,000 after buying an additional 42,822 shares during the last quarter. Raymond James & Associates lifted its stake in shares of iShares Biotechnology ETF by 4.4% during the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after buying an additional 7,931 shares during the period. Osaic Holdings Inc. boosted its position in iShares Biotechnology ETF by 9.4% during the first quarter. Osaic Holdings Inc. now owns 160,173 shares of the financial services provider’s stock worth $21,985,000 after acquiring an additional 13,777 shares during the last quarter. Finally, Albion Financial Group UT grew its stake in iShares Biotechnology ETF by 0.3% in the 3rd quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock worth $18,925,000 after acquiring an additional 356 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 2.6 %

Shares of IBB opened at $140.09 on Friday. iShares Biotechnology ETF has a fifty-two week low of $116.70 and a fifty-two week high of $150.57. The stock has a fifty day moving average of $144.68 and a two-hundred day moving average of $141.56.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.